MGO One Seven’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $792K | Buy |
5,003
+185
| +4% | +$25K | 0.01% | 799 |
|
|
2026
Q1 | $615K | Sell |
4,818
-464
| -9% | -$57.9K | 0.01% | 827 |
|
|
2025
Q4 | $644K | Buy |
5,282
+823
| +18% | +$94.4K | 0.01% | 785 |
|
|
2025
Q3 | $447K | Sell |
4,459
-43
| -1% | -$3.87K | 0.01% | 853 |
|
|
2025
Q2 | $373K | Sell |
4,502
-180
| -4% | -$14.4K | 0.01% | 838 |
|
|
2025
Q1 | $380K | Sell |
4,682
-227
| -5% | -$20.3K | 0.01% | 726 |
|
|
2024
Q4 | $442K | Sell |
4,909
-172
| -3% | -$16.7K | 0.02% | 659 |
|
|
2024
Q3 | $502K | Sell |
5,081
-57
| -1% | -$5.6K | 0.02% | 579 |
|
|
2024
Q2 | $476K | Buy |
5,138
+12
| +0.2% | +$1.08K | 0.02% | 579 |
|
|
2024
Q1 | $486K | Sell |
5,126
-1,983
| -28% | -$184K | 0.03% | 524 |
|
|
2023
Q4 | $635K | Sell |
7,109
-114
| -2% | -$8.47K | 0.04% | 445 |
|
|
2023
Q3 | $527K | Sell |
7,223
-54,484
| -88% | -$4.35M | 0.04% | 414 |
|
|
2023
Q2 | $5.13M | Sell |
61,707
-7,801
| -11% | -$652K | 0.47% | 43 |
|
|
2023
Q1 | $5.3M | Buy |
69,508
+38,008
| +121% | +$3.15M | 0.34% | 72 |
|
|
2022
Q4 | $2.61M | Buy |
31,500
+26,817
| +573% | +$2.17M | 0.26% | 94 |
|
|
2022
Q3 | $438K | Buy |
4,683
+340
| +8% | +$28.7K | 0.02% | 421 |
|
|
2022
Q2 | $323K | Sell |
4,343
-174
| -4% | -$13.1K | 0.04% | 445 |
|
|
2022
Q1 | $406K | Sell |
4,517
-160
| -3% | -$14.8K | 0.04% | 422 |
|
|
2021
Q4 | $524K | Buy |
4,677
+120
| +3% | +$14.5K | 0.05% | 373 |
|
|
2021
Q3 | $569K | Sell |
4,557
-105
| -2% | -$13.5K | 0.07% | 308 |
|
|
2021
Q2 | $631K | Buy |
4,662
+56
| +1% | +$7.36K | 0.09% | 280 |
|
|
2021
Q1 | $624K | Sell |
4,606
-510
| -10% | -$76.4K | 0.11% | 243 |
|
|
2020
Q4 | $720K | Buy |
5,116
+330
| +7% | +$42.3K | 0.15% | 179 |
|
|
2020
Q3 | $533K | Sell |
4,786
-56
| -1% | -$6.28K | 0.13% | 224 |
|
|
2020
Q2 | $542K | Hold |
4,842
| – | – | 0.14% | 202 |
|
|
2020
Q1 | $374K | Sell |
4,842
-70
| -1% | -$6.2K | 0.13% | 236 |
|
|
2019
Q4 | $467K | Buy |
4,912
+7
| +0.1% | +$605 | 0.12% | 232 |
|
|
2019
Q3 | $374K | Hold |
4,905
| – | – | 0.11% | 258 |
|
|
2019
Q2 | $430K | Sell |
4,905
-60
| -1% | -$5.12K | 0.14% | 211 |
|
|
2019
Q1 | $449K | Hold |
4,965
| – | – | 0.15% | 204 |
|
|
2018
Q4 | $356K | Sell |
4,965
-55
| -1% | -$4.43K | 0.15% | 153 |
|
|
2018
Q3 | $481K | Buy |
+5,020
| New | +$487K | 0.23% | 123 |
|
|
2018
Q1 | $437K | Buy |
4,982
+395
| +9% | +$36.1K | 0.2% | 121 |
|
|
2017
Q4 | $389K | Buy |
+4,587
| New | +$384K | 0.18% | 136 |
|
Other funds holding XBI
JFG
MGO One Seven's XBI Position: Q2 2026 in Review
MGO One Seven increased its State Street SPDR S&P Biotech ETF (XBI) stake by 3.8% in Q2 2026, buying an estimated $25K and bringing the position to 5,003 shares worth $792K. The position accounts for 0.01% of the portfolio, ranked #799.
MGO One Seven first reported a position in XBI in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.3M in Q1 2023. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- MGO One Seven held 5,003 shares of State Street SPDR S&P Biotech ETF worth $792K as of Q2 2026.
- MGO One Seven bought 185 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $25K.
- State Street SPDR S&P Biotech ETF made up 0.01% of MGO One Seven's portfolio in Q2 2026, its #799 holding.
- MGO One Seven first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and has held it in 34 quarters since.
- MGO One Seven's State Street SPDR S&P Biotech ETF position peaked at $5.3M in Q1 2023.
- 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.